CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- 4 Open-market sale Chief Medical Officer sold 2,078 shares at $79.50 ($165,201)
- 4 Gift President/CEO and Board Chair gave 51,885 shares (gift)
- 4 Planned sale President/CEO and Board Chair sold 6,000 shares at $55.37 ($332,220)
- 4 Gift Director gave 2,000 shares (gift)
- 4 Option exercise Director acquired 1,334 shares (option exercise)
- 4 Open-market sale Director sold 27,116 shares at $57.00 ($1,545,612)
- 4 Planned sale President/CEO and Board Chair sold 6,000 shares at $50.00 ($300,000)
- 4 Open-market sale See Remarks sold 13,608 shares at $40.42 ($550,035)
- 4 Open-market sale Chief Medical Officer sold 1,006 shares at $41.08 ($41,326)
- 4 Option exercise Director acquired 3,350 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 3,350 shares (option exercise)
- 4 Option exercise Director acquired 3,350 shares (option exercise)
- 4 Option exercise Director acquired 3,350 shares (option exercise)
- 4 Option exercise Director acquired 3,350 shares (option exercise)
- 4 Planned sale Chief Commercial Officer sold 17,500 shares at $43.76 ($765,800)
- 4 Open-market sale President/CEO and Board Chair sold 6,000 shares at $50.00 ($300,000)
- 4 Open-market sale Chief Commercial Officer sold 10,565 shares at an average $47.88 ($505,856)
- 4 Open-market sale Chief Operating Officer sold 7,583 shares at an average $47.89 ($363,142)
- 4 Open-market sale General Counsel sold 9,686 shares at an average $47.88 ($463,766)
Page 4 of 17 · 330 filings